Pathological reorganization of NMDA receptors subunits and postsynaptic protein PSD-95 distribution in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Alzheimer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/15672050113106660170PMID 24156266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distribution of Extrasynaptic NMDA Receptors on Neurons

  2012cited by this paper
• Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections

  2012cited by this paper
• Dual use of immunohistochemistry for film densitometry and light microscopy.

  2012cited by this paper
• NR2B-Containing NMDA Receptors Expression and Their Relationship to Apoptosis in Hippocampus of Alzheimer’s Disease-Like Rats

  2012cited by this paper
• Amyloid β peptide oligomers directly activate NMDA receptors.

  2011cited by this paper
• The role of the ubiquitin proteasome system in Alzheimer's disease

  2011cited by this paper
• Aβ oligomers induce glutamate release from hippocampal neurons.

  2011cited by this paper
• Linking Amyloid-β and Tau: Amyloid-β Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton

  2011cited by this paper
• Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

  2011cited by this paper
• Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer’s disease

  2011cited by this paper
• Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease.

  2011cited by this paper
• Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer’s disease

  2011cited by this paper
• Review: Disruption of the Postsynaptic Density in Alzheimer’s Disease and Other Neurodegenerative Dementias

  2010cited by this paper
• N‐Methyl‐d‐aspartate receptors are required for synaptic targeting of Alzheimer’s toxic amyloid‐β peptide oligomers

  2010cited by this paper
• Reduction in Post-Synaptic Scaffolding PSD-95 and SAP-102 Protein Levels in the Alzheimer Inferior Temporal Cortex is Correlated with Disease Pathology

  2010cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• PSD-95 Uncouples Dopamine–Glutamate Interaction in the D1/PSD-95/NMDA Receptor Complex

  2009cited by this paper
• Is Alzheimer's Disease a Result of Presynaptic Failure? - Synaptic Dysfunctions Induced by Oligomeric β-Amyloid

  2009cited by this paper
• The effects of aging on N-methyl-D-aspartate receptor subunits in the synaptic membrane and relationships to long-term spatial memory.

  2009cited by this paper
• Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease.

  2009cited by this paper
• Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

  2009cited by this paper
• NMDA receptor–dependent signaling pathways that underlie amyloid β‐protein disruption of LTP in the hippocampus

  2009cited by this paper
• Different expression of NR2B and PSD‐95 in rat hippocampal subregions during postnatal development

  2009cited by this paper
• β-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure*

  2009cited by this paper
• NMDA receptors in clinical neurology: excitatory times ahead.

  2008cited by this paper
• Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity.

  2008cited by this paper
• Excitation Control: Balancing PSD-95 Function at the Synapse

  2008cited by this paper
• PSD-95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling

  2008cited by this paper
• Amyloid beta peptides and glutamatergic synaptic dysregulation.

  2008cited by this paper
• Differential Changes in Synaptic Proteins in the Alzheimer Frontal Cortex with Marked Increase in PSD-95 Postsynaptic Protein

  2008influential reference
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction.

  2008cited by this paper
• Synaptic accumulation of PSD-95 and synaptic function regulated by phosphorylation of serine-295 of PSD-95.

  2007cited by this paper
• Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.

  2007cited by this paper
• Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

  2007cited by this paper
• NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

  2007cited by this paper
• Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95–neuroligin

  2007cited by this paper
• BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation

  2007cited by this paper
• Rapid bidirectional switching of synaptic NMDA receptors.

  2007cited by this paper
• Heavy chain of cytoplasmic dynein is a major component of the postsynaptic density fraction

  2006cited by this paper
• NMDA receptors are not alone: dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol-rich membrane domains leads to disease-specific nuances of glutamate-signalling.

  2006cited by this paper
• Differential Control of Postsynaptic Density Scaffolds via Actin-Dependent and -Independent Mechanisms

  2006cited by this paper
• Premorbid effects of APOE on synaptic proteins in human temporal neocortex.

  2006cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-beta.

  2005cited by this paper
• Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction

  2005cited by this paper
• The synaptic Aβ hypothesis of Alzheimer disease

  2005cited by this paper
• The synaptic Abeta hypothesis of Alzheimer disease.

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-β

  2005cited by this paper
• Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay.

  2004cited by this paper
• Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal.

  2004cited by this paper
• Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly.

  2004cited by this paper
• PDZ domain proteins of synapses

  2004cited by this paper
• Functional neurochemistry of Alzheimer's disease.

  2004cited by this paper
• Functional Neurochemistry of Alzheimers Disease

  2004cited by this paper
• Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology.

  2004cited by this paper
• Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression.

  2003cited by this paper
• Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways

  2002cited by this paper
• Plasticity and behavior: new genetic techniques to address multiple forms and functions.

  2001cited by this paper
• Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

  2000cited by this paper
• Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease.

  1999cited by this paper
• Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer’s disease and Lewy body variant

  1997cited by this paper
• Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease.

  1986cited by this paper
• Frontiers in Aging Neuroscience Aging Neuroscience Review Article

  year unknowncited by this paper

• Maf1 loss regulates spinogenesis and attenuates cognitive impairment in Alzheimer’s disease

  2024cites this paper
• Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder

  2023cites this paper
• Association of Polygenic Score and the involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder

  2023cites this paper
• Altered gene expression in excitatory neurons is associated with Alzheimer's disease and its higher incidence in women

  2023cites this paper
• The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: from pathophysiology to therapeutic approaches.

  2023cites this paper
• Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex

  2021cites this paper
• EpiMOGA: An Epistasis Detection Method Based on a Multi-Objective Genetic Algorithm

  2021cites this paper
• Amyloid-β (1-42) peptide induces rapid NMDA receptor-dependent alterations at glutamatergic synapses in the entorhinal cortex.

  2021cites this paper
• Aconiti lateralis Radix Praeparata inhibits Alzheimer’s disease by regulating the complex regulation network with the core of GRIN1 and MAPK1

  2021cites this paper
• Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease

  2021cites this paper
• Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks

  2020cites this paper
• Association between polymorphisms in the GRIN1 gene 5′ regulatory region and schizophrenia in a northern Han Chinese population and haplotype effects on protein expression in vitro

  2019cites this paper
• Structured Genome-Wide Association Studies with Bayesian Hierarchical Variable Selection

  2019cites this paper
• Alterations in Morphology and Adult Neurogenesis in the Dentate Gyrus of Patched1 Heterozygous Mice

  2018cites this paper
• Improved synaptic and cognitive function in aged 3 × Tg-AD mice with reduced amyloid-β after immunotherapy with a novel recombinant 6Aβ15-TF chimeric vaccine.

  2018cites this paper
• Cholesterol and Fat Metabolism in Alzheimer’s Disease

  2017cites this paper
• Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders

  2017cites this paper
• Protective effects of Dendrobium nobile Lindl. alkaloids on amyloid beta (25–35)-induced neuronal injury

  2017cites this paper
• Impact of Synaptic Localization and Subunit Composition of Ionotropic Glutamate Receptors on Synaptic Function: Modeling and Simulation Studies

  2017cites this paper
• Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer's disease

  2017cites this paper
• Impact of synaptic localization and subunit composition of ionotropic glutamate receptors on synaptic function: modeling and simulation studies.

  2017cites this paper
• A novel recombinant 6Aβ15-THc-C chimeric vaccine (rCV02) mitigates Alzheimer’s disease-like pathology, cognitive decline and synaptic loss in aged 3 × Tg-AD mice

  2016cites this paper
• Investigation of strategies to ameliorate beta-amyloid mediated deficits in hippocampus-dependent synaptic plasticity

  2016cites this paper
• NeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer's disease

  2016cites this paper
• RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining

  2016cites this paper
• Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases

  2016influential citation
• p120‐catenin is necessary for neuroprotection induced by CDK5 silencing in models of Alzheimer's disease

  2016cites this paper
• Effects of postmortem delays on protein composition and oxidation.

  2016cites this paper
• A Novel Aβ B-Cell Epitope Vaccine (rCV01) for Alzheimer’s Disease Improved Synaptic and Cognitive Functions in 3 × Tg-AD Mice

  2016cites this paper
• Développement préclinique de sondes fluorées utilisées dans l'imagerie moléculaire des pathologies neurodégénératives

  2015cites this paper
• p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing

  2015cites this paper
• A framework to understand the variations of PSD-95 expression in brain aging and in Alzheimer's disease.

  2014cites this paper